Filter
220
Filtered Results: 220
Text search:
Ethiopian
Food,
Medicine
and
Healthcare
Administration
and
Control
Authority
Featured
Recommendations
26
New Publications
81
Language
Document type
No document type
118
Studies & Reports
47
Guidelines
28
Strategic & Response Plan
12
Manuals
10
Training Material
3
Situation Updates
2
Countries / Regions
Ethiopia
71
Kenya
14
Global
14
Ghana
7
Africa
6
Nigeria
5
Uganda
5
Zambia
4
South Africa
4
Sierra Leone
3
Pakistan
3
South Sudan
3
Liberia
2
Jordan
2
Tanzania
2
Malawi
2
Sudan
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Western and Central Europe
2
Morocco
1
Saudi Arabia
1
Philippines
1
India
1
Somalia
1
Nepal
1
Iraq
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Rwanda
1
Namibia
1
Ukraine
1
Greece
1
Myanmar / Burma
1
South–East Asia Region
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Albania
1
Iran
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
21
Public Health
14
Key Resources
14
Women & Child Health
11
Capacity Building
5
Pharmacy & Technologies
4
Toolboxes
Pharmacy
17
TB
15
COVID-19
13
AMR
10
Caregiver
9
NTDs
9
HIV
8
Mental Health
7
Global Health Education
7
Rapid Response
6
Planetary Health
5
Conflict
4
Ebola
2
Cholera
2
Refugee
2
Health Financing Toolbox
2
NCDs
2
Disability
1
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic ...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this editi...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-he...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-... in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings
recommended
SIAPS Technical Report. This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 ext...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of maternal and child health services. As part of these efforts, ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD ..., and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD ..., and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential ..., which are a crucial part of the delivery of highquality health care services. Because medicines are costly and poor management so often results in waste, good supply management is also crucial to the cost-effectiveness of providing medicines.
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcing them into terrible choices that no one should eve...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out h...
The Sphere Handbook. Humanitarian Charter and Minimum Standards in Humanitarian Response. New Edition
recommended
Humanitarian Charter and Minimum Standards in Humanitarian Response.
The 2018 Sphere Handbook builds on the latest developments and learning in the humanitarian sector. Among the improvements of th...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s eliminatio...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,0...
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3...
